Introduction {#S1}
============

Walking requires refined coordination of muscle activation. The current theory in motor control suggests the central nervous system acts to simplify this complexity by the recruitment of a small number of muscle synergies ([@B40]). A muscle synergy, or module, is the balanced temporal activation of a group of muscles to create a specific movement. These patterns have also been described as primitives due to their nature as building blocks for movement and because they are linked to ancestral generation of locomotion, observed across a number of animal species ([@B11]).

Understanding these fundamental motor control strategies may help to develop effective treatments for individuals with impaired motor function. In individuals with neurologic impairment, such as cerebral palsy (CP), selective motor control (SMC) is often affected. SMC has been defined as "the ability to isolate the activation of muscles in a selected pattern in response to demands of a voluntary movement or posture" ([@B30]). Impaired SMC has been linked to damage in the corticospinal tract ([@B14]), limiting the ability of an individual to modulate muscle activation required for an efficient walking pattern. Impaired SMC can be quantified by clinical measures such as the selective control assessment of the lower extremities ([@B15]) and has a direct relationship with the level of gait impairment ([@B7]). Muscle synergy analysis has been used to quantify the impairment of SMC during gait analysis in children with CP ([@B35]; [@B37]; [@B31]). Using non-negative matrix factorization (NNMF) of measured surface electromyography (EMG), it has been shown that a few muscle synergy patterns can describe over 90% of measured muscle activity, or total variance accounted for (tVAF), in the majority of typically developing (TD) individuals during walking ([@B35]; [@B5], [@B6]). Most individuals with CP show a reduced number of synergies compared to TD children ([@B35]), indicating a different motor control strategy. These methods to quantify SMC have been linked to success of treatment outcomes across a range of treatment strategies ([@B31]; [@B32]).

The extent of adaptability and plasticity of muscle synergies during walking is not fully understood. Synergies are considered the base unit of control for movement. If synergies are unchanging neural circuits, this may imply that little can be done to train improved motor functions in individuals with impaired SMC during walking. The developing child brain shows high plasticity. The number and complexity of muscle synergies evolve with age, and distinct changes can be discerned from neonate, to toddler, to adult ([@B11]). This plasticity may be targeted in children with neurologic impairment. If synergies can be adapted, it may present a promising strategy for rehabilitation.

It is often considered that children with CP have limited potential to adapt gait pattern with conservative treatment; however, with real-time biofeedback, children with CP are able to improve aspects of gait in an immediate response ([@B1]; [@B42]; [@B3]). While they can achieve this change in gait, it is not known how this is achieved at the neural level. Gait training was found to subtly influence synergy composition and timing in some individuals post-stroke, which was associated with improved walking performance ([@B27]). It may be that to reach a more typical gait pattern, recruitment of a more complex synergistic strategy is required. If it is possible to adapt synergy patterns with biofeedback, this might form a promising technique to train SMC with the goal of improving gait. Furthermore, those with greater synergistic complexity may show increased capacity to adapt gait with training. Targeting SMC plasticity in children with neurological impairment could have large implications on the long-term effectiveness of treatment interventions.

Therefore, the aim of this study was to establish if SMC, as quantified using synergy analysis during gait, is changed when children with CP are challenged to improve aspects of gait with real-time biofeedback. A secondary aim was to assess whether children showing greater gait improvements in response to biofeedback have less impaired SMC than those with more limited adaptability of gait.

Materials and Methods {#S2}
=====================

Participants {#S2.SS1}
------------

Twenty-five children with CP and related (hereditary) forms of spastic paresis were recruited in this study. Children were included under the following criteria: diagnosis of spastic paresis (unilateral and bilateral), walking without aids -- for CP gross motor function classification system (GMFCS) level I-II ([@B25]) -- and aged between 5 and 16 years old. Children were excluded if they had severe cognitive or visual impairment; had received botulinum toxin-A treatment within the previous 6 months; or had orthopedic surgery, intrathecal baclofen treatment, or selective dorsal rhizotomy within 12 months prior to measurement date. Children were recruited from the VU University Medical Center, Amsterdam and Revant Rehabilitation Center, Breda. In addition, 27 TD children (aged 10.0 ± 2.11, range: 5--16 years) were included to provide reference normative data for treadmill walking. All parents and children aged 12 years and older provided written informed consent prior to participation. The protocol was approved by the medical ethics committee of the VU University Medical Center (NL56736.029.1). The kinematic and kinetic analysis of this dataset is presented in a separate manuscript ([@B3]).

Study Design {#S2.SS2}
------------

All participants walked on an instrumented treadmill with an immersive virtual reality environment (GRAIL, Motek Medical, Amsterdam, Netherlands. [Figure 1](#F1){ref-type="fig"}). A 10-camera 3D motion capture (Vicon, Oxford, United Kingdom) system was used with 26 retroreflective markers placed on anatomical landmarks. This allowed for real-time gait analysis using the human body model ([@B41]; [@B13]). A non-weight bearing safety harness was worn in all conditions to prevent injury in case of accidental slip.

![**Top:** Experimental setup with treadmill with dual force plates and virtual reality screen (Motek Medical, Amsterdam). 3D motion capture (Vicon, Oxford) is integrated with virtual reality using D-Flow software (Motek Medical, Amsterdam) to provide real-time gait analysis and visualization. **Bottom:** Visual biofeedback presented, background environment removed from image in figure for clarity. Biofeedback involved visualization of movement in real time using simplified avatar. Color-coded biofeedback was attached to an avatar providing feedback on (A) step length (goal to step on the blocks), (B) knee extension (goal to reach the green area of "fan," showing knee extension in swing), and (C) ankle power (goal to increase "power-bar" at the ankle during push-off).](fphys-10-01208-g001){#F1}

Following a period of at least 6 min habituation to walking on the treadmill, self-selected comfortable walking speed was fixed. This speed was maintained throughout the session. Participants initially carried out 1 min of comfortable walking. Baseline gait function was used to set individual targets for subsequent biofeedback trials. Targets were adapted during trials based on individual response to maintain motivation. Participants performed a series of trials, in a randomized order, lasting 2 min, in which they were challenged to improve gait in response to avatar-based real-time biofeedback on step length, knee extension during late swing and ankle push off power ([Figure 1](#F1){ref-type="fig"}). Feedback on ankle power and knee extension was provided on the most affected side only and visualized only during the target phase of the gait cycle. Most impaired limb was either indicated by the clinician or analysis of the child's baseline walking to assess which had the greatest limitation from typical walking. These specific targets for biofeedback were chosen as they were considered commonly observed clinically relevant gait parameters of different nature (spatiotemporal, kinematic and kinematic parameters, respectively).

Electromyography {#S2.SS3}
----------------

Surface electromyography data (MiniWave, Cometa, Italy) were collected at 1000 Hz on 8 muscles of the lower leg: gluteus medius, rectus femoris, vastus lateralis, semitendinosus, tibialis anterior, gastrocnemius medialis, soleus, and peroneus longus muscles following SENIAM guidelines ([@B18]). For each individual, only the most involved limb, on which biofeedback was provided, was used for analysis. Initial contact and toe-off instances were based on vertical ground reaction forces and marker data ([@B43]). EMG data were digitally processed for analysis in the following sequence: (1) band-pass filtered at 20--450 Hz, (2) full wave rectified, and (3) low-pass filtered at 10 Hz to obtain a linear envelope. For all filtering steps, bidirectional 6th order Butterworth filters were used to prevent time drift. EMG envelopes for each muscle were time-normalized to gait cycles. Signals of all trials were normalized to mean dynamic activation of each muscle during the baseline walking trial. To reduce within-subject variability, yet maximize number of steps included, a random sample of the minimum number of strides available from any trial across each participant was concatenated, providing a synergy input matrix of 8×(101×*minimumno*.*strides*)per walking trial. On average 34.4 ± 9.7 strides were concatenated for analysis (range: 13--49 strides).

Synergy Analysis {#S2.SS4}
----------------

Muscle synergies during walking were quantified as a measure for SMC using NNMF (MATLAB v2017a, MathWorks, MA, United States) with 100 max iterations and 1000 replicates. NNMF is a widely used mathematical algorithm for condensing measured muscle activation into sets of synergistic action ([@B37]; [@B34]).

Each muscle activation can be best described by the synergy timing co-efficient (C) and the relative weighting (W) of each muscle toward this synergy timing, with an additional error of the reconstructed signal, following:
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where W is a *m × n* matrix with *m* the number of muscles (eight) and *n* the specified number of synergies (from one to five in this analysis). C is an *n × t* matrix where *t* is the number of time points. To maximize data available for analysis, in the event of missing or erroneous EMG signals, this channel was given zero weight and not incorporated into the NNMF, i.e., NNMF for the trial analysis would then be calculated for 7 muscles ([@B32]). How well the extracted synergies describe measured EMG activity was calculated by the tVAF at each synergy solution ([@B38]), such that tVAF = 1 -*SSE*/SST, where the sum squared of errors (SSE) is the unexplained variation and total sum of squares (SST) is the pooled variation of data. No thresholds for synergy computation were applied. The minimum number of synergies required to describe at least 90% of tVAF of the measured EMG was defined as an indicative threshold for redundancy, following ([@B8]; [@B24]; [@B29]).

### Similarity of Synergies {#S2.SS4.SSS1}

To allow for comparison of synergy structures and weightings between individuals and trials, we further investigated the four-synergy level solution. From preliminary analysis, four synergies were sufficient to describe at least 90% tVAF in the majority of TD participants. Therefore, by exploring the four-synergy solution in greater detail, we minimized the risk of missing nuances between synergies.

The composite first, second, third, and fourth synergies were sorted to identify best matched pairs of synergy patterns to baseline within an individual. In an iterative approach we compared the synergies in two sets by computing the similarities between the best matched pairs of weightings. The two with the highest similarity were paired, then removed from the process. The procedure was repeated until all synergies had been matched ([@B9]). No threshold for synergy pairing similarity was applied. Synergies were grouped by functional muscle group weightings and ordered by timings. The first synergy was weighted highest toward gluteus medius activity, second synergy weighted highest toward ankle plantarflexor muscle action, the third synergy was weighted highest toward tibialis anterior, and the highest toward semitendinosus was designated the fourth.

Similarities between synergy compositions \[both muscle weightings (W) and timing co-efficient (C)\] were compared by computing the cosine similarity ([@B9]; [@B23]; [@B24]; [@B26]). Similarity prioritizes likeness in vector shape as opposed to magnitude shift. Similarity of 1 represents perfect similarity. Following [@B16] and [@B24], a similarity between a pair of synergies of above 0.8 was defined as similar ([@B16]; [@B24]).

High-Responders vs. Low-Responders {#S2.SS5}
----------------------------------

To establish a relationship between adaptability in gait and synergy complexity, we grouped individuals as high-responders and low-responders to biofeedback. High-responders were defined as those able to reach at least 5^o^ more maximal knee extension during initial contact, at least 10% increased step length, and 10% increase in ankle power generation at push off with direct biofeedback. Low-responders were defined as those able to reach no more than one of these targets. Seven participants were considered high-responders, attaining all three targets of biofeedback. Eight participants were grouped as low-responders. The remaining participants reached 2/3 of these condition targets and were excluded for this analysis.

Statistical Analysis {#S2.SS6}
--------------------

To test the difference in number of synergies across feedback trials, a Wilcoxon signed-rank was used to test differences from baseline. To establish group changes in synergies across feedback trials, between-condition (baseline, step length, knee extension, and ankle power feedback) differences in tVAF~1--5~ were evaluated with repeated measure ANOVAs. CP and TD group outcomes for tVAF at each synergy level were compared with independent *t*-tests for baseline walking only. Differences across biofeedback trials in synergy weighting composition of the four-synergy solution were evaluated with multiple Friedman's test; α was reduced to 0.01 to reduce Type 1 error. *Post hoc* testing was carried out to indicate significant changes from baseline. To explore differences in high-responders and low-responders, group average tVAF~1~ was compared using a Two-Way RM-ANOVA, with feedback condition and group (high-responders/low-responders) as factors. The number of synergies during baseline for each group was also compared using a Wilcoxon signed-rank test. Analyses were performed using SPSS software (IBM SPSS Statistics 23, Armonk, NY, United States) with standard α = 0.05 and Bonferroni correction applied for multiple *post hoc* comparisons.

Results {#S3}
=======

Due to technical issues in data collection, two participants were excluded because of missing data. As such, 23 children were included in analysis (demographics presented in [Table 1](#T1){ref-type="table"}). In response to biofeedback, children with CP showed the capacity to adapt gait. Step length was increased 12.7 ± 11.3%, knee extension at initial contact increased by 7.4 ± 7.1^o^, and peak ankle power at push off improved 37.7 ± 36.1% ([@B3]). The grouped average, processed and normalized EMG signals for all eight muscles during the walking trials are plotted in [Figure 2](#F2){ref-type="fig"}.

###### 

Participant demographics in CP group (*n* = 23) and TD reference group.

  **Characteristic**    **Mean ± SD or *n***           **Range**   **TD (*n* = 27)**
  --------------------- ------------------------------ ----------- -------------------
  Age (years)           10.4 ± 3.1                     6--16       10.9 ± 3.0
  Height (m)            1.51 ± 0.20                    1.27--1.9   1.52 ± 0.20
  Body mass (kg)        41.2 ± 17.8                    26.1--89    43.0 ± 12.6
  Walking speed (m/s)   0.65 ± 0.18                    0.35--1.1   1.05 ± 0.24
  Diagnosis             CP: 21, HSP: 2                             --
  GMFCS                 I: 11, II: 12                              --
  Localization          Unilateral: 8, Bilateral: 15               --
  Sex                   M: 16, F: 9                                M: 10, F: 17

CP, cerebral palsy; HSP, hereditary spastic paresis; GMFCS, gross motor function classification system; TD, typically developing.

![Mean muscle activation pattern across gait cycle during biofeedback trials. Gray shaded area represents average typically developing (TD) data during treadmill walking ± 1SD. Gluteus medius (GM), rectus femoris (RF), vastus lateralis (VL), semitendinosus (ST), tibialis anterior (TA), gastrocnemius medialis (GA), soleus (SO), and peroneus longus (PL).](fphys-10-01208-g002){#F2}

Variance Accounted for {#S3.SS1}
----------------------

A three-synergy solution described at least 90% of tVAF in 13 out of 27 TD children during baseline walking, while 13 TD children required four synergies and one child required five. In contrast, most children with CP required two or three synergies ([Figure 3](#F3){ref-type="fig"}). During feedback trials, in children with CP, the number of synergies required to describe ≥90% of tVAF changed for some individuals. With biofeedback on ankle power, ten children required one extra synergy to describe ≥90% of tVAF, one child required two extra synergies while one required one fewer synergy; this amounted to a significant increase in the number of synergies compared to baseline (*Z* = −2.673, *p* = 0.008). No significant changes were found with biofeedback on knee extension or step length ([Figure 3](#F3){ref-type="fig"}).

![Number of synergies required to describe at least 90% of measured muscle activation across walking trials. TD, shown for reference. ^∗^ indicates significant difference to baseline (*p* = 0.008, Wilcoxon signed-rank).](fphys-10-01208-g003){#F3}

Changes in tVAF were small -- for all individuals who changed by one synergy level, this was the result of a small (\<5%) change in tVAF (Mean Δ: 2.2 ± 1.3%). Group average tVAF~1~ showed no difference, baseline: 0.75 ± 0.08, step length: 0.76 ± 0.05, knee extension: 0.74 ± 0.07, and ankle power 0.76 ± 0.05. No change was found in tVAF~1,3,4,5~ with any of the biofeedback conditions (*p* \> 0.05) ([Figure 4](#F4){ref-type="fig"}). There was a significant effect of biofeedback in tVAF~2~, with *post hoc* tests showing tVAF~2~ during step length biofeedback was significantly higher than baseline \[*F*(3,66) = 2.992, *p* = 0.044\]. Comparing the groups, children with CP showed less complex SMC compared to TD children as measured by tVAF~1~ ([Figure 4](#F4){ref-type="fig"}), with lower scores for TD (0.64 ± 0.03) than for the CP group (0.75 ± 0.08) during baseline walking \[*t* (48) = 6.200, *p* \< 0.001; tVAF~2--5,~ *p* \< 0.05\].

![Total variance accounted for (tVAF) from one to five synergy solutions for typically developing children (TD) and for children with CP across biofeedback trials. For each cluster, individual scores are plotted with dots, white middle bar shows mean, shading shows 95% CI, while solid color represents SD. † represents significant difference between TD and CP group (*p* \< 0.05, independent *t*-test). ^∗^ Significant effect of biofeedback was found in tVAF~2~ (*p* = 0.046, *post hoc* RM-ANOVA). No further significant differences between baseline and any of the biofeedback conditions were found (*p* \> 0.05).](fphys-10-01208-g004){#F4}

Within-Subject Similarity {#S3.SS2}
-------------------------

The structure of synergy weightings and timings between feedback trials remained relatively consistent across the group ([Figure 5](#F5){ref-type="fig"}). There was no significant interaction effect of feedback on composition muscle weightings (*p* \> 0.01). High within-subject similarities (\>0.8) to baseline were found in both weighting and timing ([Figure 6](#F6){ref-type="fig"}). Across the four-synergy solution, weightings showed similarity to baseline of 0.91 ± 0.08, 0.88 ± 0.09, and 0.90 ± 0.07 for step length, knee extension, and ankle power feedback, respectively. Synergy timings showed a similar trend, with similarities of 0.93 ± 0.06, 0.91 ± 0.06, and 0.92 ± 0.04 for step length, knee extension, and ankle power feedback, respectively. Individual responses across trials are shown in [Supplementary Data Sheet 1](#SM1){ref-type="supplementary-material"}.

![Synergy timing pattern **(left)** for the four-synergy solution. Corresponding muscle weightings **(right)** of each synergy pattern across feedback trials. Reference TD pattern shown in gray. Gluteus medius (GM), rectus femoris (RF), vastus lateralis (VL), semitendinosus (ST), tibialis anterior (TA), gastrocnemius medialis (GA), soleus (SO), and peroneus longus (PL). No significant difference in muscle weightings from baseline in *post hoc* testing (*p* \> 0.01, RM-ANOVA).](fphys-10-01208-g005){#F5}

![Analysis of the within-subject cosine similarity to baseline of matched paired muscle synergies for an imposed four-synergy solution across feedback trials. Similarity of weightings **(top)** and timing co-efficient **(bottom)**. For each cluster, individual results are plotted with dots, white middle bar shows mean, shading shows 95% CI, while solid color represents SD.](fphys-10-01208-g006){#F6}

High-Responders vs. Low-Responders {#S3.SS3}
----------------------------------

The high-responders (*n* = 7) were aged 12.7 ± 2.1 years; GMFCS I = 3, II = 4; and unilateral = 1, bilateral = 6. Low-responders (*n* = 8) were aged 9.1 ± 2.7 years; GMFCS I = 4, II = 4; and unilateral = 5, bilateral = 3. The responders group showed an average tVAF~1~ score at baseline of 0.74 ± 0.08 compared to 0.78 ± 0.07 for the non-responders (*p* = 0.311, independent *t*-test). The results of the two-way mixed ANOVA showed that there was no significant interaction effect between high-responders/low-responders and biofeedback condition on tVAF~1~ \[*F*(3,39) = 2.126, *p* = 0.130, η~p~^2^ = 0.141\]. No difference was found in the number of synergies required in the high-responders group (3.1 ± 0.9) and low-responder group (2.6 ± 0.7) during baseline walking and across all biofeedback trials (*p* = 0.370). Grouped synergy composition of high-responders and low-responders and shown in [Supplementary Data Sheet 2](#SM2){ref-type="supplementary-material"}.

Discussion {#S4}
==========

The goal of this study was to explore the underlying SMC in children with CP associated with changes in gait in response to real-time biofeedback during treadmill walking. Children with CP showed adaptability in gait to reach the targets of biofeedback, reaching significant and meaningful improvements in gait kinematics, kinetics, and spatiotemporal parameters. When considering SMC, we found contradictory results with a small yet significant change in tVAF and number of synergies required to describe SMC in response to biofeedback. Within-subject similarity of weightings and timing for an imposed four-synergy solution were high across the feedback trials. These results suggest that while gait may be adapted in an immediate response to biofeedback, it is questionable if this involves an adaptation of SMC.

In this study we found subtle changes in synergies between comfortable walking and adapted walking with biofeedback. We observed changes when considering the number of synergies required to reach a threshold of at least 90% tVAF ([@B8]; [@B11]; [@B35]). Eleven participants required more synergies to describe muscle activity during walking with ankle power feedback than during baseline walking. Both individual and group differences in tVAF, however, were small ([Figure 4](#F4){ref-type="fig"}). For all individuals who changed by one synergy level, this was the result of a small (\<5%) change in tVAF (Mean Δ: 2.2 ± 1.3%). We found a change in group tVAF~2~, with values significantly higher during step length biofeedback than during baseline, which could indicate slightly adaptable SMC. However, absolute difference in mean tVAF~2~ between baseline and step length trials was small, less than 2% tVAF. Further investigation is required to establish meaningful change at the level of an individual; therefore, it may be questioned if these small changes are clinically relevant. The limited change in synergy structure is also reflected in the EMG profiles; while amplitude is adapted, the activation pattern shows high similarity to baseline walking (\>0.93 cosine similarity). Moreover, the structure of synergistic action showed high consistency across trials. When investigating the imposed four-synergy solution, we observed high within-subject similarity (\>0.8) of both weighting and timing of synergies. This result ties with recent findings that -- following intervention in children with CP and significant changes in gait -- while changes in the number of synergies are found, there is high similarity ([@B33]). Further to this, TD children show consistent muscle synergies when walking at different speeds and slopes ([@B29]). This provides further evidence toward the theory that synergies are neural in nature and are consistent over similar functional tasks. Similarity of synergies as found in our study is comparable to reported studies ([@B28]; [@B26]; [@B29]; [@B33]).

The alternative explanation for individual variation in weightings and timings is that biofeedback-driven gait adaptations are in fact resulting in subtly adapted SMC, reflected in slight changes in synergy composition. It should be noted, however, that one of the limitations of using cosine similarity is that the similarity due to chance is high (∼0.75). Therefore, changes under this value may reflect significant adaptation. However, given the minor changes in tVAF and high overall similarity, we cannot convincingly support this from our findings.

Contrary to expectations, we could not establish a trend toward the use of tVAF as a predictor of adaptability in gait. Similar to previous findings, we showed that ambulatory children with CP show a higher tVAF at each synergy level when compared to TD children ([@B35]; [@B5], [@B6]; [@B17]). This is further evidence that synergy analysis may relate to functional motor impairments, with tVAF~1~ indicative for the complexity of SMC. If individuals with lower tVAF~1~ do have a capacity for more complex SMC, it may be expected that they would also have greater ability to adapt gait in response to biofeedback by a more refined recruitment of muscles. Our results cannot confirm this hypothesis, as no difference was found between high-responders and low-responders to the challenges of biofeedback. However, we were limited in this analysis by a small subsample size. In addition, the functional differences between the groups were small. All participants were ambulatory children, and all were able to adapt gait to some extent in response to biofeedback. Further exploration of this concept with larger and more distinct populations is required to establish the use of tVAF~1~ as a proxy measure of the capacity of an individuals' gait adaptability.

There are limitations in inferring SMC from the presented method of synergy analysis. The use of synergies as a measure of SMC is not yet fully understood, and there is a lack of general consensus ([@B39]). One critique is that muscle synergies reflect a functional task constraint rather than neural control strategies ([@B10]). In our study, the functional task of walking was similar between conditions. While gait changes in kinematics were considerable, the individuals were carrying out a highly similar functional task: walking. For example, in animal models there is evidence of shared synergies even between differing functional tasks such as walking, swimming and jumping ([@B9]). The targets of biofeedback were not chosen as those that may have the largest effect on synergy composition, more so toward clinical improvements in walking. There is evidence to suggest that plantarflexor activity may be particularly important for synergy composition and walking ability ([@B27]; [@B17]). While ankle power may be considered a proxy for plantarflexor activation, perhaps targeting this specifically with biofeedback will yield more significant changes.

The presented method of synergy analysis may not be sensitive enough to quantify these adaptations in gait. Synergy analysis is influenced by the number and selection of specific muscles ([@B36]). To reveal the complexity of synergies, concatenating at least 20 steps is recommended ([@B24]). It may be of interest to consider strides individually to investigate variability. This study does not report step-to-step variability; tVAF can be reduced by increasing variability, and this may have been induced by the novel biofeedback condition. This potentially explains some of the changes we see in tVAF. By concatenating a large number of strides, we hoped to reduce this effect. Children with CP exhibit greater stride-to-stride variability than TD children, and this may relate to walking impairment ([@B20]). With further practice it may be that timing and variation can be improved, resulting in functional improvements. Synergies are also sensitive to data processing of EMG ([@B34]). By implementing a standard method of EMG processing, we can expect to minimize these discrepancies. Eight muscles from one leg were used in the present study. Gait, however, is a whole-body movement and many muscles across the body contribute to overall function. An important limitation of this study is that biofeedback was provided on only the most affected side. In addition, EMG analysis is reported only on this side. As such, we cannot quantify the resultant effect on the opposite leg. It may be that additional adaptations in muscle activation are being made on this leg. Future studies would benefit from bilateral EMG analysis to provide a comprehensive overview of SMC. By measuring a limited number of muscles, it may be difficult to fully establish the underlying SMC. Activation of small or deep muscles that were not measured in this present study may have important influence. It is likely that synergies provide the building block for functional movement, but these may be supplemented with refined control to achieve specific modifications in movement. In our measured EMG activity, a peak around initial contact is evident. It is expected that this is the result of hyper-reflexive reaction to muscle stretch following initial contact. Many of the subjects reported spasticity of the calf muscles and walked in a toe-gait pattern. This activity may influence the extrapolation of synergies.

Our study population consisted of a range of ages, functional ability, and diagnosis. These factors influence the composition of synergies and may contribute to the lack of change identified at a group level. While adults with HSP have been shown to display impaired locomotor co-ordination ([@B21]), further research is required to directly compare CP and HSP pediatric populations. The lack of clear changes in muscle synergies may have implications for rehabilitation of neurological impairment. Synergies have been shown to be related to functional impairment ([@B35]), with more impaired individuals showing reduced effectiveness of interventions across multiple centers ([@B32]). Given that synergies appear to be relatively consistent, it may cast doubt on the ability of individuals with neurological impairment to adapt and improve motor tasks such as walking. Nevertheless, gait training has been shown to be effective in improving walking function in individuals with impaired SMC, such as CP ([@B4]) and post-stroke ([@B22]). Synergies mature over the years in early development ([@B11]) and may be associated with developmental re-structuring of the spinal cord ([@B19]). Perhaps it should not be expected that synergies are altered in a short-term response to changes in gait as done in this study. Such gait adaptation may require a prolonged period of practice before it is innately learned and recruited. In a 12-week gait training intervention for individuals post-stroke, synergy module timings were found to be somewhat adapted, alongside improved walking performance ([@B27]). To the authors' knowledge there are no studies looking at changes in synergies associated with prolonged gait training interventions in individuals with CP. It may be that gait training with biofeedback, initiated at an early age, would be most effective in developing and learning improved SMC. With direct biofeedback, children with CP are able to alter muscle activations during gait ([@B2]; [@B12]). In combination with our results, these studies highlight the potential adaptability of gait in children with CP. Therefore, future research should investigate potential adaptation of SMC after a prolonged period of gait training with the addition of biofeedback.

Conclusion {#S5}
==========

Children with CP can selectively adapt and improve aspects of gait when challenged with biofeedback. Subtle changes in synergy patterns and tVAF were identified; however, it is unclear if these changes are clinically important. Within-subject similarity of synergies was high across the biofeedback trials. These results suggest that while gait may be adapted in an immediate response, SMC as quantified by synergy analysis is perhaps more rigidly impaired in CP. Adaptations may be limited in the short term, and further investigation is essential to establish if long-term training using biofeedback leads to adapted SMC.
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